购物车
- 全部删除
- 您的购物车当前为空
HNHA 是组蛋白去乙酰化酶抑制剂。它通过 p21诱导将细胞周期阻滞在 G1/S 期,抑制肿瘤生长及肿瘤新生血管形成。HNHA 可能是一种有效的抗乳腺癌药物。
为众多的药物研发团队赋能,
让新药发现更简单!
HNHA 是组蛋白去乙酰化酶抑制剂。它通过 p21诱导将细胞周期阻滞在 G1/S 期,抑制肿瘤生长及肿瘤新生血管形成。HNHA 可能是一种有效的抗乳腺癌药物。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 529 | 现货 | |
2 mg | ¥ 771 | 现货 | |
5 mg | ¥ 1,120 | 现货 | |
10 mg | ¥ 2,120 | 现货 | |
25 mg | ¥ 3,590 | 现货 | |
50 mg | ¥ 5,180 | 现货 | |
100 mg | ¥ 7,330 | 现货 | |
500 mg | ¥ 14,600 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 1,220 | 现货 |
产品描述 | HNHA is an inhibitor of HDAC. |
靶点活性 | HDAC:100 nM |
体外活性 | Treatment of cells with HNHA could elicite histone hyperacetylation resulting in an up-regulation of cell cycle arrest, p21 transcription, and an inhibition of HT1080 cell invasion. HNHA was able to inhibit in-vitro HDAC enzyme activity as well as proliferation of human fibrosarcoma cells (HT1080). |
体内活性 | Several HDAC inhibitors, including MS-27-275 and a hydroxyamide-based HDAC inhibitors such as SAHA have been investigated extensively and shown to inhibit tumor growth in vivo. |
分子量 | 303.42 |
分子式 | C17H21NO2S |
CAS No. | 926908-04-5 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
溶解度信息 | Ethanol: 15 mg/mL (49.44 mM) DMSO: 15 mg/mL (49.44 mM) | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
Ethanol/DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.